Showing results (1911-1920 of 2,046) with videos related to
Sort By:
Pageof 205
The Journal of Physiology|May 17, 2019
UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophyRobert A Seaborne, David C Hughes, Daniel C Turner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized StudyMassimo Cristofanilli, Hope S Rugo, Seock-Ah Im, et al.Current Therapeutic Research, Clinical and Experimental|December 1, 2025
The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical StudiesSimon Eng, Michael Fetell, Haitao Gao, et al.JCO Oncology Practice|June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineChristina M Lockwood, Hans J Messersmith, Annette S Kim, et al.Allergy|January 13, 2019
AllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paperEva Untersmayr, Heather J Bax, Christoph Bergmann, et al.Archives of Pathology & Laboratory Medicine|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working GroupJ Pascual, G Attard, F-C Bidard, et al.Scandinavian Journal of Work, Environment & Health|February 22, 2023
Association of occupational heat exposure and colorectal cancer in the MCC-Spain studyAlice Hinchliffe, Manolis Kogevinas, Antonio J Molina, et al.Nature Communications|March 31, 2026
Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancerJackson Liang, Christy Ong, Kareem Heslop, et al.Nature Communications|May 31, 2020
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancerNeha Chopra, Holly Tovey, Alex Pearson, et al.Pageof 205